Commerzbank Aktiengesellschaft Moderna, Inc. Transaction History
Commerzbank Aktiengesellschaft
- $3.03 Billion
- Q2 2024
A detailed history of Commerzbank Aktiengesellschaft transactions in Moderna, Inc. stock. As of the latest transaction made, Commerzbank Aktiengesellschaft holds 5,550 shares of MRNA stock, worth $668,220. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,550
Previous 5,457
1.7%
Holding current value
$668,220
Previous $582,000
13.4%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding MRNA
# of Institutions
1,052Shares Held
244MCall Options Held
12.1MPut Options Held
9.35M-
Baillie Gifford & CO43.4MShares$5.23 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39MShares$4.7 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$3.06 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.74 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.16 Billion67.87% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $47.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...